Summary
Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO) saw its stock increase by 7.4% after revealing a new clinical study collaboration with AGEPHA Pharma focused on treating inflammation-driven coronary heart disease.
Source: InvestorsHub on MSN.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
